Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. NLM AIDSLINE Important note: Information in this article was accurate in 1980. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Sexual transmission of hepatitis A in homosexual men: incidence and mechanism.

N Engl J Med. 1980 Feb 21;302(8):435-8. Unique Identifier : AIDSLINE MED/80099535
Corey L; Holmes KK

Abstract: We performed monthly examinations and serologic tests for antibody to hepatitis virus A (anti-HA) in a study of 57 heterosexual men and 102 homosexual men followed prospectively for a mean of 8.9 months and 6.1 months, respectively. The initial prevalence of anti-HA was 30 per cent in homosexual men and 12 per cent in heterosexual men P less than 0.01). The annual incidence of hepatitis A in susceptible (seronegative) homosexual men was 22 per cent, whereas no heterosexual men acquired hepatitis A. Diaries concerning sexual behavior kept by homosexual men showed that the acquisition of hepatitis A virus infection contact. Hepatitis A should be considered one of the enteric infections that appear to be sexually transmitted among homosexual men.
Keywords: Adolescence Adult Antibodies, Viral/ANALYSIS Hepatitis A/EPIDEMIOLOGY/*TRANSMISSION Hepatovirus/IMMUNOLOGY *Homosexuality Human Male Middle Age Prospective Studies Retrospective Studies Sex Behavior *Sexually Transmitted Diseases/EPIDEMIOLOGY Support, U.S. Gov't, P.H.S. Washington JOURNAL ARTICLEKWDadolescenceadultantibodies,viral/analysishepatitisa/epidemiology/KWDtransmissionhepatovirus/immunologyKWDhomosexualityhumanmalemiddleageprospectivestudiesretrospectivestudiessexbehaviorKWDsexuallytransmitteddiseases/epidemiologysupport,uKWDsKWDgov't,pKWDhKWDsKWDwashingtonjournalarticle
800530
M8050001

Copyright © 1980 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1980. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1980. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .